All Industries

Top Drug Discovery Companies

1,077 Drug Discovery companies, sorted by total funding raised.

Gemelli Biotech

Gemelli Biotech provides clinically validated at-home breath and blood tests that help patients a...

Biotech, Diagnostics
Series ATotal funding$19.0MJun 2022
SCOHIA PHARMA

SCOHIA PHARMA discovers oral drugs for cardiovascular, metabolic, and growth-hormone disorders, a...

Biotech, Drug Discovery
Venture RoundTotal funding$18.8MMay 2026
SCANOGEN INC.

R&D company with 11 SBIR/STTR awards from Department of Health and Human Services.

Baltimore, United States11–50Biotech, Healthcare
GrantTotal funding$17.6MSep 2025
STI Technologies
Drug Discovery, Healthcare
Private EquityTotal funding$17.0MSep 2013
Amide

Rapid robotic synthesis of valuable peptides and protein structures.

Cambridge, United States11–50Biotech, Drug Discovery
Extension RoundTotal funding$16.5MJul 2023
Cancer Targeted Technology LLC

R&D company with 7 SBIR/STTR awards from Department of Health and Human Services.

PULLMAN, United States1–10Biotech, Drug Discovery
GrantTotal funding$16.2MSep 2025
General Proximity

General Proximity builds a mechanism-agnostic proximity discovery engine to develop therapeutics ...

San Francisco, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$16.0MMay 2026
POLAREAN, INC.

R&D company with 1 SBIR/STTR awards from Department of Health and Human Services.

Durham, United States1–10Healthcare, Manufacturing
Corporate RoundTotal funding$15.6MJun 2024
ACX

ACX develops bioengineered crop-protection solutions that reduce chemical dependence and promote ...

New York, United States1–10Agtech, Biotech
Pre-seedTotal funding$15.5MOct 2024
Alternative Bio

Precision oncology biotech developing first-in-class therapeutics targeting post-translational mo...

Hong Kong, Hong Kong1–10Biotech, Healthcare
SeedTotal funding$15.0MDec 2022
Persephone Biosciences

Persephone develops a first-of-its-kind synbiotic pairing keystone probiotics with prebiotics fou...

San Diego, United States1–10Drug Discovery, Healthcare
SeedTotal funding$15.0M
Akari TherapeuticsIPO

Biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.

London, United Kingdom1–10Biotech, Drug Discovery
Venture RoundTotal funding$14.6MDec 2025
RyboDyn

RyboDyn develops first-in-class immunotherapies by unlocking the dark proteome and targeting prev...

San Diego, United States1–10Biotech, Healthcare
SeedTotal funding$14.3MMar 2026
Champions OncologyIPO

Global preclinical research and clinical specialty testing provider driving excellence in oncolog...

Hackensack, United States201–500Biotech, Drug Discovery
Corporate RoundTotal funding$14.0MMar 2015
Experic
Drug Discovery, Manufacturing
Extension RoundTotal funding$14.0MOct 2023
Carogen Corporation

R&D company with 4 SBIR/STTR awards from Department of Health and Human Services.

Hamden, United States1–10Biotech, Healthcare
GrantTotal funding$13.7MJan 2022
Parcel Biosciences

Developer of programmable mRNA delivery technology to diverse cell types in the body; next-genera...

San Francisco, United States1–10Biotech, Drug Discovery
SeedTotal funding$13.5MMay 2026
CareRxIPO
CanadaDrug Discovery, Healthcare
Growth EquityTotal funding$13.0MJan 2021
ResistanceBioClosed

We solve drug resistance for cancer

Menlo Park, United States11–50Drug Discovery, Healthcare
SeedTotal funding$12.8MJan 2024
Qvin

Qvin develops FDA-cleared diagnostic menstrual pads that collect menstrual blood, offering people...

Menlo Park, United States11–50Digital Health, Drug Discovery
Series ATotal funding$12.4MOct 2020
MDI THERAPEUTICS INC

R&D company with 4 SBIR/STTR awards from Department of Health and Human Services.

Novi, United States1–10Biotech, Drug Discovery
GrantTotal funding$12.2MMar 2022
COLLAGEN MEDICAL LLC

R&D company with 15 SBIR/STTR awards from Department of Health and Human Services.

Boston, United States1–10Healthcare, Medical Devices
GrantTotal funding$12.2MSep 2024
Cerium Pharmaceuticals

Cerium Pharmaceuticals is dedicated to creating therapies for patients with kidney diseases, incl...

Biotech, Drug Discovery
Series BTotal funding$12.0M
RS Research

Clinical-stage biotech developing smart nanomedicines and targeted cancer therapies using its pro...

Biotech, Drug Discovery
Series ATotal funding$12.0M
Valink Therapeutics

Valink Therapeutics develops first-in-class bispecific antibody-drug conjugates and other modalit...

Boston, United States11–50Biotech, Drug Discovery
Pre-seedTotal funding$11.8MOct 2025